一名曾因英夫利昔单抗诱发肝炎的患者对依那西普的耐受性 - Suppr

Suppr

超能文献

Etanercept tolerance in a patient with previous infliximab-induced hepatitis.

作者信息

Becker Heidemarie, Willeke Peter, Domschke Wolfram, Gaubitz Markus

出版信息

Clin Rheumatol. 2008 Dec;27(12):1597-8. doi: 10.1007/s10067-008-1000-3. Epub 2008 Sep 16.

DOI:10.1007/s10067-008-1000-3

PMID:18795397

Abstract

摘要

相似文献

Etanercept tolerance in a patient with previous infliximab-induced hepatitis.一名曾因英夫利昔单抗诱发肝炎的患者对依那西普的耐受性

Clin Rheumatol. 2008 Dec;27(12):1597-8. doi: 10.1007/s10067-008-1000-3. Epub 2008 Sep 16.

TNF-alpha inhibition: the need for a tumor necrosis factor thermostat.肿瘤坏死因子-α抑制：对肿瘤坏死因子“恒温器”的需求

Mayo Clin Proc. 2001 Jun;76(6):573-5.

Mechanisms of differential immunogenicity of tumor necrosis factor inhibitors.肿瘤坏死因子抑制剂的差异免疫原性机制。

Curr Rheumatol Rep. 2005 Mar;7(1):3-9. doi: 10.1007/s11926-005-0002-2.

TNF inhibitors: a new age in rheumatoid arthritis treatment.肿瘤坏死因子抑制剂：类风湿关节炎治疗的新时代。

Am J Nurs. 2004 Feb;104(2):60-8; quiz 68-9. doi: 10.1097/00000446-200402000-00023.

Inhibitors of tumor necrosis factor: new treatment options for rheumatoid arthritis.肿瘤坏死因子抑制剂：类风湿关节炎的新治疗选择

Cleve Clin J Med. 1999 Jun;66(6):367-74. doi: 10.3949/ccjm.66.6.367.

[Anti-TNF alpha agents in patients with rheumatoid arthritis refractory to conventional therapies].[类风湿关节炎患者对传统治疗难治时使用抗肿瘤坏死因子α制剂的情况]

Med Clin (Barc). 2010 May 22;134(15):684-5. doi: 10.1016/j.medcli.2009.12.003. Epub 2010 Feb 21.

Drug-specific and time-dependent risks of bacterial infection among patients with rheumatoid arthritis who were exposed to tumor necrosis factor alpha antagonists.暴露于肿瘤坏死因子α拮抗剂的类风湿关节炎患者发生细菌感染的药物特异性和时间依赖性风险。

Arthritis Rheum. 2007 Dec;56(12):4226-7. doi: 10.1002/art.23050.

Effects of etanercept or infliximab treatment on lipid profile and insulin resistance in patients with refractory rheumatoid arthritis.依那西普或英夫利昔单抗治疗对难治性类风湿关节炎患者血脂谱和胰岛素抵抗的影响。

Clin Rheumatol. 2007 Oct;26(10):1799-800. doi: 10.1007/s10067-007-0702-2. Epub 2007 Jul 24.

Tumor necrosis factor-alpha blockade and the risk of vasculitis.肿瘤坏死因子-α阻断与血管炎风险

J Rheumatol. 2004 Oct;31(10):1885-7.

[TNF targetting therapy for rheumatoid arthritis].[类风湿关节炎的肿瘤坏死因子靶向治疗]

Nihon Naika Gakkai Zasshi. 2006 Sep 10;95(9):1787-94. doi: 10.2169/naika.95.1787.

引用本文的文献

Biologic and Checkpoint Inhibitor-Induced Liver Injury: A Systematic Literature Review.生物制剂和检查点抑制剂所致肝损伤：一项系统文献综述

Hepatol Commun. 2020 Jan 2;4(2):172-184. doi: 10.1002/hep4.1465. eCollection 2020 Feb.

Drug-Induced Liver Injury: Pattern Recognition and Future Directions.药物性肝损伤：模式识别与未来方向

Gut Liver. 2016 Jan;10(1):27-36. doi: 10.5009/gnl15114.

Anti-tumour necrosis factor agent and liver injury: literature review, recommendations for management.抗肿瘤坏死因子药物与肝损伤：文献综述及管理建议

World J Gastroenterol. 2014 Dec 14;20(46):17352-9. doi: 10.3748/wjg.v20.i46.17352.

Tumor necrosis factor-α inhibitors and chronic hepatitis C: a comprehensive literature review.肿瘤坏死因子-α抑制剂与慢性丙型肝炎：全面文献综述。

World J Gastroenterol. 2013 Nov 28;19(44):7867-73. doi: 10.3748/wjg.v19.i44.7867.

Liver injury from tumor necrosis factor-α antagonists: analysis of thirty-four cases.肿瘤坏死因子-α拮抗剂致肝损伤：34 例分析。

Clin Gastroenterol Hepatol. 2013 May;11(5):558-564.e3. doi: 10.1016/j.cgh.2012.12.025. Epub 2013 Jan 17.

Autoimmune hepatitis induced by adalimumab with successful switch to abatacept.阿达木单抗诱发的自身免疫性肝炎，成功转换为阿巴西普治疗。

Eur J Clin Pharmacol. 2012 May;68(5):895-8. doi: 10.1007/s00228-011-1191-4. Epub 2011 Dec 29.

Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management.自身免疫性肝炎：发病机制、诊断和治疗的新范式。

Hepatol Int. 2010 May 19;4(2):475-93. doi: 10.1007/s12072-010-9183-5.

Intern Emerg Med. 2010 Jun;5(3):193-200. doi: 10.1007/s11739-009-0342-4. Epub 2010 Jan 27.

本文引用的文献

A case of autoimmune hepatitis exacerbated by the administration of etanercept in the patient with rheumatoid arthritis.1例类风湿关节炎患者使用依那西普后加重自身免疫性肝炎的病例。

Clin Rheumatol. 2008 Aug;27(8):1063-6. doi: 10.1007/s10067-008-0885-1. Epub 2008 Jun 18.

Serious liver disease induced by infliximab.英夫利昔单抗诱发的严重肝脏疾病。

Clin Rheumatol. 2007 Apr;26(4):578-81. doi: 10.1007/s10067-005-0169-y. Epub 2006 Mar 18.

Use of etanercept in treatment of pyoderma gangrenosum in a patient with autoimmune hepatitis.依那西普在一名自身免疫性肝炎患者坏疽性脓皮病治疗中的应用。

J Dermatolog Treat. 2005;16(5-6):347-9. doi: 10.1080/09546630500424722.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验